Skip to main content
. Author manuscript; available in PMC: 2011 Aug 24.
Published in final edited form as: ACS Nano. 2010 Aug 24;4(8):4621–4636. doi: 10.1021/nn100975c

Figure 6.

Figure 6

In vitro efficacy of PTX/PEG-HCCs. Treatment of two head and neck cancer cell lines (a,b) and two breast cancer cell lines (c,d) with PTX/PEG-HCCs (blue line with circles) and PTX/Cremophor (red line with triangles). Plot (a) also shows the inability of PEG-HCCs alone to kill cells (green line with squares). Each graph represents an individual trial. Error bars are standard errors. Table (e) presents the IC50 data for an average of three trials and the standard deviations.